Evidence map›Paper›PMID 32218156›Full record

ArticleInternational journal of molecular sciences2020

Fast-Acting and Receptor-Mediated Regulation of Neuronal Signaling Pathways by Copaiba Essential Oil.

Yasuyo Urasaki, Cody Beaumont, Michelle Workman, Jeffery N Talbot, David K Hill, Thuc T Le

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Toxicological Effects of Copaiba Oil (Plants (Basel, Switzerland) · 2023
    Review
  6. An integratedFrontiers in pharmacology · 2023
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Akt3 Regulates the Tissue-Specific Response to Copaiba Essential Oil.International journal of molecular sciences · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yasuyo UrasakiCollege of Pharmacy, Roseman University of Health Sciences, 10530 Discovery Drive, Las Vegas, NV 89135, USA.
Cody BeaumontdōTERRA International, LLC, 389 South 1300 West, Pleasant Grove, UT 84062, USA.
Michelle WorkmandōTERRA International, LLC, 389 South 1300 West, Pleasant Grove, UT 84062, USA.
Jeffery N TalbotCollege of Pharmacy, Roseman University of Health Sciences, 10530 Discovery Drive, Las Vegas, NV 89135, USA.
David K HilldōTERRA International, LLC, 389 South 1300 West, Pleasant Grove, UT 84062, USA.
Thuc T LeCollege of Pharmacy, Roseman University of Health Sciences, 10530 Discovery Drive, Las Vegas, NV 89135, USA.
Roseman University of Health Sciences · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study examined the biological activities of copaiba essential oil via measurement of its effects on signaling pathways in the SH-SY5Y neuronal cell line. Nanofluidic proteomic technologies were deployed to measure the phosphorylation of biomarker proteins within the signaling cascades. Interestingly, copaiba essential oil upregulated the pI3K/Akt/mTOR, MAPK, and JAK/STAT signaling pathways in neuronal cells. The effects of copaiba essential oil peaked at 30 min post-treatment, with a half-maximal effective concentration (EC

Indexed as

Cell Line, TumorCyclic AMP-Dependent Protein KinasesFabaceaeHumansNeuroblastomaOils, VolatilePhosphatidylinositol 3-KinasesPlant OilsSignal TransductionTOR Serine-Threonine KinasesCyclic AMP-Dependent Protein KinasesMTOR protein, humanOils, VolatilePhosphatidylinositol 3-KinasesPlant OilsTOR Serine-Threonine Kinasesapoptosiscapillary isoelectric focusingcopaiba essential oilJAK/STATMAPKnanofluidic proteomicsneuronal signaling pathwayspI3K/Akt/mTORprotein post-translational modificationβ-caryophyllene

Identifiers

PMID32218156
PMCPMC7177672
OpenAlexW3013555045

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.